|
Index of reports
> Disability (63)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) disability. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 63 Next >>
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-23
Patient:
Reactions: Anal Fistula, Anorectal Discomfort, Haemorrhoids, Anaemia, Adverse Event
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Start date: 2012-05-25
Ribasphere
Dosage: 200mg in am 400mg pm
Other drugs received by patient: Procrit; Telaprevir
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Haemoglobin Decreased, Anaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Start date: 2012-06-05
End date: 2012-06-25
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
PEG-Intron
Dosage: 1.5mcg/kg
Indication: Hepatitis C
Start date: 2012-06-05
End date: 2012-07-10
PEG-Intron
Dosage: 50mcg/week
Start date: 2012-06-26
End date: 2012-07-09
Other drugs received by patient: Miglitol; Metformin HCL
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Cheilitis, Rash
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
End date: 2012-05-31
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-29
Telavic
Administration route: Oral
Start date: 2012-06-01
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Other drugs received by patient: Urso 250
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: daily dosage unknown
Indication: Hepatitis C
Start date: 2010-01-01
Rebetol
Dosage: daily dosage unknown
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-01-01
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Viral Load Increased, Vomiting, Contusion, Paranoia, Hyperhidrosis, Polyneuropathy, Joint Stiffness, Hallucination, Visual, Diarrhoea, Treatment Failure, Infection
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Start date: 2008-01-01
End date: 2008-07-01
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2006-12-01
End date: 2007-08-01
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2006-12-01
End date: 2007-08-01
Rebetol
Dosage: unk
Start date: 2008-01-01
End date: 2008-07-01
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Myalgia, Bedridden, Vomiting, Fatigue, Nausea, Photophobia, Headache, Muscle Spasms
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Victrelis
Indication: Hepatitis C
PEG-Intron
Ribasphere
Possible PEG-Intron side effects in male
Reported by a individual with unspecified qualification from France on 2012-08-09
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Tooth Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Possible PEG-Intron side effects in male
Reported by a individual with unspecified qualification from France on 2012-08-09
Patient: male, weighing 61.0 kg (134.2 pounds)
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-09
Patient:
Reactions: Bowel Movement Irregularity, Tinnitus, Feeling Hot, Anaemia, Loss of Consciousness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-20
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-09
Patient:
Reactions: Bowel Movement Irregularity, Tinnitus, Feeling Hot, Anaemia, Loss of Consciousness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-20
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient:
Reactions: Procedural Pain, Back Pain, Hepatic Pain, Arthralgia, Panic Reaction, Influenza Like Illness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-29
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient:
Reactions: Dyspnoea, Anaemia, Rash, Headache, Generalised Oedema, Anxiety, Gastrointestinal Pain, Fatigue, Diarrhoea, Visual Impairment, Depression, Mood Swings, Cough, Decreased Appetite
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribasphere
Dosage: unk
Start date: 2012-04-27
End date: 2012-07-16
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-07-16
Telaprevir
Dosage: unk
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from France on 2012-07-26
Patient:
Reactions: Tooth Disorder
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 30 ?g, qw
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Placebo
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded Post Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Peginterferon Alfa-2B
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2007-10-18
End date: 2010-07-22
Blinded PRE Trial Therapy
Dosage: 800 mg, qd
Start date: 2007-10-18
End date: 2010-07-22
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-23
Patient:
Reactions: Encephalopathy, Ascites
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Victrelis
Dosage: 200 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-02
End date: 2012-06-08
Rebetol
Indication: Hepatitis C
PEG-Intron
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19
Patient:
Reactions: Bowel Movement Irregularity, Tinnitus, Anaemia, Feeling Hot, Loss of Consciousness
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2011-08-20
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-22
Possible PEG-Intron side effects in
Reported by a physician from Bulgaria on 2012-07-19
Patient:
Reactions: Macular Oedema, Blindness, Papilloedema
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Rebetol
Administration route: Oral
Indication: Hepatitis C
Possible PEG-Intron side effects in 61 year old male
Reported by a physician from United States on 2012-06-13
Patient: 61 year old male
Reactions: Gastrointestinal Motility Disorder, Pain, Impaired Work Ability, Emotional Disorder, Haemoglobin Increased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: bid
Indication: Hepatitis C
Start date: 2012-05-01
PEG-Intron
Dosage: qw
Indication: Hepatitis C
Start date: 2012-05-01
Other drugs received by patient: Vitamins E; Vitamins C
Possible PEG-Intron side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12
Patient: male
Reactions: Weight Decreased, Pruritus, Substance Use, Hunger, Abnormal Dreams, Back Pain, Polydipsia, Pain in Extremity, Eye Inflammation, Foreign Body Sensation in Eyes, Application Site Pain, Insomnia, Rash Erythematous, Pancreatitis, Injection Site Discolouration, Chills, Pain, Poor Quality Sleep, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Blood Glucose Increased, Decreased Appetite, Vomiting, Nausea, Musculoskeletal Chest Pain, Application Site Rash, Dysgeusia, Burning Sensation, Pollakiuria, Asthenia, Feeling Abnormal, Influenza
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2012-04-06
PEG-Intron
Indication: Hepatitis C
Start date: 2012-04-06
Possible PEG-Intron side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12
Patient: 50 year old male
Reactions: Haemoglobin Decreased, Dyspnoea, Arthralgia, Abdominal Distension
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
PEG-Intron
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Megace; Zoloft
Possible PEG-Intron side effects in 68 year old male
Reported by a physician from Japan on 2012-06-11
Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Blood Bilirubin Increased, Contusion, Pruritus, Ear Haemorrhage, Anaemia, Laceration, Rash, Fall, Subdural Haematoma, Skull Fractured Base, Hearing Impaired, Blood Creatinine Increased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2012-02-02
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-06
End date: 2012-04-19
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-20
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-29
Rebetol
Dosage: 800;600;400;200 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-01
End date: 2012-04-05
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-26
Telavic (Antivirals Nos)
Dosage: 2250;1500 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-04-12
Other drugs received by patient: Voltaren; Actos; Glyburide; Epadel-S; Actos
Possible PEG-Intron side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08
Patient: male
Reactions: Tinnitus, Faecal Incontinence, Loss of Consciousness
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
Start date: 2011-07-22
PEG-Intron
Indication: Hepatitis C
Start date: 2011-07-22
Victrelis
Indication: Hepatitis C
Start date: 2011-08-20
Possible PEG-Intron side effects in 54 year old female
Reported by a pharmacist from United States on 2012-06-04
Patient: 54 year old female
Reactions: Drug Dose Omission, Spinal Pain, Pain in Extremity, Drug Ineffective, Chest Pain, Muscle Spasms, Mobility Decreased
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Dilaudid
Possible PEG-Intron side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31
Patient: 55 year old female
Reactions: Intention Tremor, Motor Dysfunction
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: qw
Indication: Hepatitis C
End date: 2011-12-01
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible PEG-Intron side effects in 59 year old female
Reported by a physician from Japan on 2012-05-30
Patient: 59 year old female, weighing 79.0 kg (173.8 pounds)
Reactions: Subarachnoid Haemorrhage, Platelet Count Decreased, Intracranial Aneurysm, Hypoaesthesia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2010-12-17
End date: 2011-01-14
PEG-Intron
Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-01-21
End date: 2011-01-27
PEG-Intron
Dosage: 120 mcg;qw;sc, 100 mcg;qw;sc, 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2010-11-05
End date: 2010-12-10
Rebetol
Dosage: 400 mg;bid;po, 200 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-11-05
End date: 2011-02-03
Rebetol
Dosage: 400 mg;bid;po, 200 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-02-04
End date: 2012-01-28
Other drugs received by patient: Amlodipine / 00972402 /; Miglitol; Juzentaihoto
Possible PEG-Intron side effects in 68 year old male
Reported by a physician from Japan on 2012-05-25
Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Blood Bilirubin Increased, Contusion, Ear Haemorrhage, Anaemia, Fall, Ear Canal Injury, Skull Fractured Base, Hearing Impaired
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg/kg, qw, sc
Indication: Hepatitis C
Start date: 2012-02-02
Rebetol
Dosage: 800;600 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-01
Rebetol
Dosage: 800;600 mg, qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-29
Other drugs received by patient: Glyburide; Actos; Epadel-S; Voltaren
Possible PEG-Intron side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14
Patient: male
Reactions: Injection Site Discolouration, Weight Decreased, Pain, Chills, Substance Abuse, Hunger, Abdominal Pain Upper, Abnormal Dreams, Myalgia, Fatigue, Liver Function Test Abnormal, Anger, Decreased Appetite, Polydipsia, Back Pain, Vomiting, Pain in Extremity, Nausea, Eye Inflammation, Musculoskeletal Chest Pain, Dysgeusia, Burning Sensation, Rash Erythematous, Pollakiuria, Pancreatitis, Asthenia, Feeling Abnormal, Mobility Decreased, Influenza
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2012-04-06
Ribavirin
Indication: Hepatitis C
Start date: 2012-04-06
Telaprevir
Indication: Hepatitis C
Start date: 2012-04-06
Possible PEG-Intron side effects in 68 year old male
Reported by a physician from Japan on 2012-04-16
Patient: 68 year old male, weighing 61.0 kg (134.2 pounds)
Reactions: Haemoglobin Decreased, Contusion, Ear Haemorrhage, Hearing Impaired, Skull Fractured Base, Fall
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Telavic (Antivirals Nos)
Dosage: 2250 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
Rebetol
Dosage: 800 mg;qd;po 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-01
Rebetol
Dosage: 800 mg;qd;po 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-02-29
PEG-Intron
Dosage: 1.5 mcg/kg;qw;sc
Indication: Hepatitis C
Other drugs received by patient: Actos; Glyburide; Voltaren; Epadel-S
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05
Patient: 57 year old female
Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
PEG-Intron
Dosage: qw
Indication: Hepatitis C
Start date: 2011-07-01
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-01
End date: 2012-01-01
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02
Patient: 57 year old female
Reactions: Pneumonia, Staphylococcal Infection, Escherichia Infection, Candidiasis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Victrelis
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Victrelis
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-01
End date: 2012-01-01
Ribavirin
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
PEG-Intron
Dosage: ;qw;
Indication: Hepatitis C
Start date: 2011-07-01
Possible PEG-Intron side effects in 26 year old male
Reported by a pharmacist from United States on 2012-03-21
Patient: 26 year old male
Reactions: Anaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Ribavirin
Dosage: 4 df, qd
Indication: Product Used FOR Unknown Indication
PEG-Intron
Dosage: 120 mcg, qw,sc
Indication: Hepatitis C
Start date: 2010-06-28
Page 1 Next >>
|
